Sustained IGF-I elevation from any GH secretagogue raises theoretical concerns IGF-I is a mitogen, and chronic elevation is a variable of interest in tissue-growth contexts that have not been evaluated for this blend over time
Will ALC be useful when used alone, or used in adults with brain diseases (like dementia, brain vascular disorders), or in older adults
Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030
A 2025 study presented at the Endocrine Societys annual meeting found that men with obesity or type 2 diabetes who used GLP-1 medications saw both significant weight loss and improved testosterone levels
These findings support the potential of ALC as both a biomarker and a therapeutic agent in mood disorders
This peptide is widely used in diabetes research and obesity management
